Your browser doesn't support javascript.
loading
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea.
Lee, Ji Yun; Kwon, Ji Hyun; Hur, Joon Young; Yi, Jun Ho; Lee, Ji Hyun; Cho, Hyungwoo; Do, Young Rok; Jo, Jae-Cheol; Kang, Hye Jin; Koh, Yougil; Lee, Won Sik; Lim, Sung Nam; Yoon, Sang Eun; Kim, Seok Jin; Lee, Jeong-Ok.
Affiliation
  • Lee JY; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Kwon JH; Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, Korea.
  • Hur JY; Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • Yi JH; Division of Hematology-Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Lee JH; Division of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
  • Cho H; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Do YR; Department of Internal Medicine, Dongsan Medical Center, Daegu, Korea.
  • Jo JC; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea.
  • Kang HJ; Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
  • Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
  • Lee WS; Department of Internal medicine, Busan Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Lim SN; Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
  • Yoon SE; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Kim SJ; Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Lee JO; Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Cancer Res Treat ; 56(2): 681-687, 2024 Apr.
Article de En | MEDLINE | ID: mdl-37946408
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome T / Lymphomes Limites: Adult / Aged / Aged80 / Humans / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Cancer Res Treat Année: 2024 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Lymphome T / Lymphomes Limites: Adult / Aged / Aged80 / Humans / Middle aged Pays/Région comme sujet: Asia Langue: En Journal: Cancer Res Treat Année: 2024 Type de document: Article